According to research on LUAD (lung adenocarcinoma) patients, TRPV1 expression is notably up-regulated in the tumor tissues, which indicates that TRPV1 might be an alternative novel target for LUAD treatment [45]. The gene discussed is TRPV1; the disease is lung adenocarcinoma.